<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34922324</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-3964</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>EBioMedicine</Title><ISOAbbreviation>EBioMedicine</ISOAbbreviation></Journal><ArticleTitle>Deconvoluting virome-wide antibody epitope reactivity profiles.</ArticleTitle><Pagination><StartPage>103747</StartPage><MedlinePgn>103747</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">103747</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ebiom.2021.103747</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2352-3964(21)00541-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Comprehensive characterization of exposures and immune responses to viral infections is critical to a basic understanding of human health and disease. We previously developed the VirScan system, a programmable phage-display technology for profiling antibody binding to a library of peptides designed to span the human virome. Previous VirScan analytical approaches did not carefully account for antibody cross-reactivity among sequences shared by related viruses or for the disproportionate representation of individual viruses in the library.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Here we present the AntiViral Antibody Response Deconvolution Algorithm (AVARDA), a multi-module software package for analyzing VirScan datasets. AVARDA provides a probabilistic assessment of infection with species-level resolution by considering sequence alignment of all library peptides to each other and to all human viruses. We employed AVARDA to analyze VirScan data from a cohort of encephalitis patients with either known viral infections or undiagnosed etiologies. We further assessed AVARDA's utility in associating viral infection with type 1 diabetes and lupus.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">By comparing acute and convalescent sera, AVARDA successfully confirmed or detected encephalitis-associated responses to human herpesviruses 1, 3, 4, 5, and 6, improving the rate of diagnosing viral encephalitis in this cohort by 44%. AVARDA analyses of VirScan data from the type 1 diabetes and lupus cohorts implicated enterovirus and herpesvirus infections, respectively.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">AVARDA, in combination with VirScan and other pan-pathogen serological techniques, is likely to find broad utility in the epidemiology and diagnosis of infectious diseases.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">This work was made possible by support from the National Institutes of Health (NIH), the US Army Research Office, the Singapore Infectious Diseases Initiative (SIDI), the Singapore Ministry of Health's National Medical Research Council (NMRC) and the Singapore National Research Foundation (NRF).</AbstractText><CopyrightInformation>Copyright &#xa9; 2021. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Monaco</LastName><ForeName>Daniel R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Department of Pathology, Division of Immunology, Institute of Cell Engineering, Johns Hopkins School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kottapalli</LastName><ForeName>Sanjay V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>Department of Pathology, Division of Immunology, Institute of Cell Engineering, Johns Hopkins School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Breitwieser</LastName><ForeName>Florian P</ForeName><Initials>FP</Initials><AffiliationInfo><Affiliation>Center for Computational Biology, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Danielle E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Programme in Emerging Infectious Diseases, Duke-NUS Medical School, 8 College Road, 169857, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wijaya</LastName><ForeName>Limin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Singapore General Hospital, 20 College Road, 169856, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Neuroscience Institute, 11 Jalan Tan Tock Seng, 308433, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chia</LastName><ForeName>Wan Ni</ForeName><Initials>WN</Initials><AffiliationInfo><Affiliation>Programme in Emerging Infectious Diseases, Duke-NUS Medical School, 8 College Road, 169857, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kammers</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Oncology, Division of Biostatistics and Bioinformatics, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caturegli</LastName><ForeName>Patrizio</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pathology, Division of Immunology, Institute of Cell Engineering, Johns Hopkins School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waugh</LastName><ForeName>Kathleen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Barbara Davis Center for Diabetes, University of Colorado Denver, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roederer</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ImmunoTechnology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petri</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Rheumatology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldman</LastName><ForeName>Daniel W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Rheumatology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rewers</LastName><ForeName>Marian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Barbara Davis Center for Diabetes, University of Colorado Denver, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lin-Fa</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Programme in Emerging Infectious Diseases, Duke-NUS Medical School, 8 College Road, 169857, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larman</LastName><ForeName>H Benjamin</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Department of Pathology, Division of Immunology, Institute of Cell Engineering, Johns Hopkins School of Medicine, Baltimore, MD, USA. Electronic address: hlarman1@jhmi.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 CA006973</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 DK032493</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK116073</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 AI118633</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 AI068613</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM136724</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI095068</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR069572</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK032493</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>EBioMedicine</MedlineTA><NlmUniqueID>101647039</NlmUniqueID><ISSNLinking>2352-3964</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000083422" MajorTopicYN="Y">Virome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antibody profiling</Keyword><Keyword MajorTopicYN="N">Encephalitis</Keyword><Keyword MajorTopicYN="N">Phage ImmunoPrecipitation Sequencing (PhIP-Seq)</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">Type 1 diabetes</Keyword><Keyword MajorTopicYN="N">VirScan</Keyword></KeywordList><CoiStatement>Declaration of interests H.B.L. is an inventor on a licensed patent describing the VirScan technology, is a founder of Portal Bioscience, Alchemab, and ImmuneID, and serves as an advisor for TScan Therapeutics. The other authors have no potential conflicts of interest to report.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>18</Day><Hour>20</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34922324</ArticleId><ArticleId IdType="pmc">PMC8688874</ArticleId><ArticleId IdType="doi">10.1016/j.ebiom.2021.103747</ArticleId><ArticleId IdType="pii">S2352-3964(21)00541-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wylie K.M., Weinstock G.M., Storch G.A. Emerging view of the human virome. Transl Res J Lab Clin Med. 2012;160(4):283&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3701101</ArticleId><ArticleId IdType="pubmed">22683423</ArticleId></ArticleIdList></Reference><Reference><Citation>Duerkop B.A., Hooper L.V. Resident viruses and their interactions with the immune system. Nat Immunol. 2013;14(7):654&#x2013;659.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3760236</ArticleId><ArticleId IdType="pubmed">23778792</ArticleId></ArticleIdList></Reference><Reference><Citation>Foxman E.F., Iwasaki A. Genome-virome interactions: examining the role of common viral infections in complex disease. Nat Rev Microbiol. 2011;9(4):254&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3678363</ArticleId><ArticleId IdType="pubmed">21407242</ArticleId></ArticleIdList></Reference><Reference><Citation>Lecuit M., Eloit M. The human virome: new tools and concepts. Trends Microbiol. 2013;21(10):510&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172527</ArticleId><ArticleId IdType="pubmed">23906500</ArticleId></ArticleIdList></Reference><Reference><Citation>Larman H.B., Zhao Z., Laserson U., Li M.Z., Ciccia A., Gakidis M.A.M., et al. Autoantigen discovery with a synthetic human peptidome. Nat Biotechnol. 2011;29(6):535&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4169279</ArticleId><ArticleId IdType="pubmed">21602805</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu G.J., Kula T., Xu Q., Li M.Z., Vernon S.D., Ndung'u T., et al. Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome. Science. 2015;348(6239):aaa0698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4844011</ArticleId><ArticleId IdType="pubmed">26045439</ArticleId></ArticleIdList></Reference><Reference><Citation>Haab B.B., Dunham M.J., Brown P.O. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2001;2(2):1&#x2013;13. research0004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC25774</ArticleId><ArticleId IdType="pubmed">11182887</ArticleId></ArticleIdList></Reference><Reference><Citation>Reymond Sutandy F., Qian J., Chen C.S., Zhu H. Overview of protein microarrays. Curr Protoc Protein Sci. 2013;27(1):27.1.1&#x2013;27.1.16. Editor Board John E Coligan AlApr;0 27:Unit-27.1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3680110</ArticleId><ArticleId IdType="pubmed">23546620</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz C., Levy-Beladev L., Rotem-Bamberger S., Rito T., R&#xfc;diger S.G.D., Friedler A. Studying protein&#x2013;protein interactions using peptide arrys. Chem Soc Rev. 2011;40(5):2131&#x2013;2145.</Citation><ArticleIdList><ArticleId IdType="pubmed">21243154</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujima A., Ochiai Y., Saito A., Omori Y., Noda A., Kazuyama Y., et al. Discrimination of antibody to herpes B virus from antibody to herpes simplex virus types 1 and 2 in human and macaque sera. J Clin Microbiol. 2008;46(1):56&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2224259</ArticleId><ArticleId IdType="pubmed">17989200</ArticleId></ArticleIdList></Reference><Reference><Citation>Rewers M., Bugawan T.L., Norris J.M., Blair A., Beaty B., Hoffman M., et al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY) Diabetologia. 1996;39(7):807&#x2013;812.</Citation><ArticleIdList><ArticleId IdType="pubmed">8817105</ArticleId></ArticleIdList></Reference><Reference><Citation>Norris J.M., Yin X., Lamb M.M., Barriga K., Seifert J., Hoffman M., et al. Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. JAMA. 2007;298(12):1420&#x2013;1428.</Citation><ArticleIdList><ArticleId IdType="pubmed">17895458</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M., Orbai A.M., Alarc&#xf3;n G.S., Gordon C., Merrill J.T., Fortin P.R., et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2012;64(8):2677&#x2013;2686.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3409311</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>Larman H.B., Laserson U., Querol L., Verhaeghen K., Solimini N.L., Xu G.J., et al. PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis. J Autoimmun. 2013;43:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3677742</ArticleId><ArticleId IdType="pubmed">23497938</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu G.J., Shah A.A., Li M.Z., Xu Q., Rosen A., Casciola-Rosen L., et al. Systematic autoantigen analysis identifies a distinct subtype of scleroderma with coincident cancer. Proc Natl Acad Sci U S A. 2016;113(47):E7526&#x2013;E7534. 22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5127349</ArticleId><ArticleId IdType="pubmed">27821747</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team (2021). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/.</Citation></Reference><Reference><Citation>Brister J.R., Ako-adjei D., Bao Y., Blinkova O. NCBI viral genomes resource. Nucleic Acids Res. 2015;43:D571&#x2013;D577. Database issue.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383986</ArticleId><ArticleId IdType="pubmed">25428358</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihara T., Nishimura Y., Shimizu Y., Nishiyama H., Yoshikawa G., Uehara H., et al. Linking virus genomes with host taxonomy. Viruses. 2016;8(3):66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4810256</ArticleId><ArticleId IdType="pubmed">26938550</ArticleId></ArticleIdList></Reference><Reference><Citation>Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J Mol Biol. 1990;215(3):403&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pubmed">2231712</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukiyama S., Ide M., Ariyoshi H., Shirakawa I. A new algorithm for generating all the maximal independent sets. SIAM J Comput. 1977;6(3):505&#x2013;517.</Citation></Reference><Reference><Citation>Gertz E.M., Yu Y.K., Agarwala R., Sch&#xe4;ffer A.A., Altschul S.F. Composition-based statistics and translated nucleotide searches: improving the TBLASTN module of BLAST. BMC Biol. 2006;4:41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1779365</ArticleId><ArticleId IdType="pubmed">17156431</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgenlander W.R., Henson S.N., Monaco D.R., Chen A., Littlefield K., Bloch E.M., et al. Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality. J Clin Investig. 2021;131(7):1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8011893</ArticleId><ArticleId IdType="pubmed">33571169</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57(1):289&#x2013;300.</Citation></Reference><Reference><Citation>Filippi C.M., von Herrath M.G. Viral trigger for type 1 diabetes. Diabetes. 2008;57(11):2863&#x2013;2871.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2570378</ArticleId><ArticleId IdType="pubmed">18971433</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehik K., Lynch K.F., Wong M.C., Tian X., Ross M.C., Gibbs R.A., et al. Prospective virome analyses in young children at increased genetic risk for type 1 diabetes. Nat Med. 2019;25:1865&#x2013;1872. doi: 10.1038/s41591-019-0667-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0667-0</ArticleId><ArticleId IdType="pmc">PMC6898786</ArticleId><ArticleId IdType="pubmed">31792456</ArticleId></ArticleIdList></Reference><Reference><Citation>Swaak T., Smeenk R. Clinical significance of antibodies to double stranded DNA (dsDNA) for systemic lupus erythematosus (SLE) Clin Rheumatol. 1987;6(1):56&#x2013;73. doi: 10.1007/BF02200721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02200721</ArticleId><ArticleId IdType="pubmed">3304800</ArticleId></ArticleIdList></Reference><Reference><Citation>Sestak A.L., F&#xfc;rnrohr B.G., Harley J.B., Merrill J.T., Namjou B. The genetics of systemic lupus erythematosus and implications for targeted therapy. Ann Rheum Dis. 2011;70(1):i37&#x2013;i43.</Citation><ArticleIdList><ArticleId IdType="pubmed">21339217</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkon K.B., Stone V.V. Type I interferon and systemic lupus erythematosus. J Interferon Cytokine Res. 2011;31(11):803&#x2013;812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3216059</ArticleId><ArticleId IdType="pubmed">21859344</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley J.B., James J.A. Epstein-Barr virus infection may be an environmental risk factor for systemic lupus erythematosus in children and teenagers. Arthritis Rheumatol. 1999;42(8):1782&#x2013;1783.</Citation><ArticleIdList><ArticleId IdType="pubmed">10446885</ArticleId></ArticleIdList></Reference><Reference><Citation>James J.A., Neas B.R., Moser K.L., Hall T., Bruner G.R., Sestak A.L., et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheumatol. 2001;44(5):1122&#x2013;1126.</Citation><ArticleIdList><ArticleId IdType="pubmed">11352244</ArticleId></ArticleIdList></Reference><Reference><Citation>Rider J.R., Ollier W.E., Lock R.J., Brookes S.T., Pamphilon D.H. Human cytomegalovirus infection and systemic lupus erythematosus. Clin Exp Rheumatol. 1997;15(4):405&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">9272302</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans A.S., Rothfield N.F., Niederman J.C. Raised antibody titres to E.B. virus in systemic lupus erythematosus. Lancet. 1971;297(7691):167&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">4102189</ArticleId></ArticleIdList></Reference><Reference><Citation>Rondaan C., Haan A., de, Horst G., Hempel J.C., Leer C van, Bos N.A., et al. Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases. Arthritis Rheumatol. 2014;66(11):3122&#x2013;3128.</Citation><ArticleIdList><ArticleId IdType="pubmed">25223407</ArticleId></ArticleIdList></Reference><Reference><Citation>Broccolo F., Drago F., Cassina G., Fava A., Fusetti L., Matteoli B., et al. Selective reactivation of human herpesvirus 6 in patients with autoimmune connective tissue diseases. J Med Virol. 2013;85(11):1925&#x2013;1934.</Citation><ArticleIdList><ArticleId IdType="pubmed">23983182</ArticleId></ArticleIdList></Reference><Reference><Citation>Jumper J., Evans R., Pritzel A., Green T., Figurnov M., Ronneberger O., et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583&#x2013;589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8371605</ArticleId><ArticleId IdType="pubmed">34265844</ArticleId></ArticleIdList></Reference><Reference><Citation>Syzonenko I., Phillips J.L. Accelerated protein folding using greedy-proximal A. J Chem Inf Model. 2020;60(6):3093&#x2013;3104.</Citation><ArticleIdList><ArticleId IdType="pubmed">32298093</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>